PF-06669571
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-06669571, covering 2017-08-07 to 2017-08-07. Get the full timeline:
Most recent: Clinical Trial Update: PF-06669571 In Subjects With Idiopathic Parkinson's Disease [Phase 1]